Multinational Internet-based survey of patient preference for newer oral or injectable Type 2 diabetes medication

BACKGROUND: The prevalence of Type 2 diabetes mellitus continues to rise. Although glucagon-like peptide-1 (GLP-1) analog and dipeptidyl peptidase-4 (DPP-4) inhibitor medications are effective, there are differences between these products, including method of administration (injectable versus oral)....

Descripción completa

Detalles Bibliográficos
Autores principales: DiBonaventura, Marco daCosta, Wagner, Jan-Samuel, Girman, Cynthia J, Brodovicz, Kimberly, Zhang, Qiaoyi, Qiu, Ying, Pentakota, Sri-Ram, Radican, Larry
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003606/
https://www.ncbi.nlm.nih.gov/pubmed/21206515
http://dx.doi.org/10.2147/PPA.S14477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003606/
https://www.ncbi.nlm.nih.gov/pubmed/21206515
http://dx.doi.org/10.2147/PPA.S14477

Ejemplares similares